Literature DB >> 27222486

Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle.

Alemu Tekewe1, Natalie K Connors1, Anton P J Middelberg1, Linda H L Lua2.   

Abstract

Virus-like particles (VLPs) and capsomere subunits have shown promising potential as safe and effective vaccine candidates. They can serve as platforms for the display of foreign epitopes on their surfaces in a modular architecture. Depending on the physicochemical properties of the antigenic modules, modularization may affect the expression, solubility and stability of capsomeres, and VLP assembly. In this study, three module designs of a rotavirus hydrophobic peptide (RV10) were synthesized using synthetic biology. Among the three synthetic modules, modularization of the murine polyomavirus VP1 with a single copy of RV10 flanked by long linkers and charged residues resulted in the expression of stable modular capsomeres. Further employing the approach of module titration of RV10 modules on each capsomere via Escherichia coli co-expression of unmodified VP1 and modular VP1-RV10 successfully translated purified modular capomeres into modular VLPs when assembled in vitro. Our results demonstrate that tailoring the physicochemical properties of modules to enhance modular capsomeres stability is achievable through synthetic biology designs. Combined with module titration strategy to avoid steric hindrance to intercapsomere interactions, this allows bioprocessing of bacterially produced in vitro assembled modular VLPs.
© 2016 The Protein Society.

Entities:  

Keywords:  Escherichia coli; co-expression; linkers; module titration; rotavirus; synthetic biology

Mesh:

Substances:

Year:  2016        PMID: 27222486      PMCID: PMC4972206          DOI: 10.1002/pro.2953

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  51 in total

Review 1.  Virus-like particles in vaccine development.

Authors:  António Roldão; Maria Candida M Mellado; Leda R Castilho; Manuel J T Carrondo; Paula M Alves
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

2.  Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.

Authors:  Joseph M Perchiacca; Ali Reza A Ladiwala; Moumita Bhattacharya; Peter M Tessier
Journal:  Protein Eng Des Sel       Date:  2012-07-27       Impact factor: 1.650

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety.

Authors:  Huai-Jie Hao; Yong-Qiang Jiang; Yu-Ling Zheng; Ru Ma; Duo-Wei Yu
Journal:  Biochimie       Date:  2005-08       Impact factor: 4.079

5.  A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.

Authors:  Anton P J Middelberg; Tania Rivera-Hernandez; Nani Wibowo; Linda H L Lua; Yuanyuan Fan; Graham Magor; Cindy Chang; Yap P Chuan; Michael F Good; Michael R Batzloff
Journal:  Vaccine       Date:  2011-06-07       Impact factor: 3.641

6.  Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.

Authors:  Susan Idicula-Thomas; Petety V Balaji
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

7.  Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels.

Authors:  Kerstin Dell; Robert Koesters; Michael Linnebacher; Corinna Klein; Lutz Gissmann
Journal:  Vaccine       Date:  2005-12-13       Impact factor: 3.641

8.  Hepatitis E vaccine development: a 14 year odyssey.

Authors:  Ting Wu; Shao-Wei Li; Jun Zhang; Mun-Hon Ng; Ning-Shao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2012-06-01       Impact factor: 3.452

9.  Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.

Authors:  Lysann Schädlich; Tilo Senger; Carsten J Kirschning; Martin Müller; Lutz Gissmann
Journal:  Vaccine       Date:  2009-01-25       Impact factor: 3.641

10.  High-level expression of soluble viral structural protein in Escherichia coli.

Authors:  Yap P Chuan; Linda H L Lua; Anton P J Middelberg
Journal:  J Biotechnol       Date:  2008-02-04       Impact factor: 3.307

View more
  2 in total

1.  An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant.

Authors:  Tushar Ahmed Shishir; Taslimun Jannat; Iftekhar Bin Naser
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.752

2.  Retrospective study, full-length genome characterization and evaluation of viral infectivity and pathogenicity of chimeric porcine deltacoronavirus detected in Vietnam.

Authors:  Kepalee Saeng-Chuto; Patumporn Jermsutjarit; Christopher J Stott; Dam Thi Vui; Angkana Tantituvanont; Dachrit Nilubol
Journal:  Transbound Emerg Dis       Date:  2019-09-13       Impact factor: 5.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.